iiinova — where your digital self keeps evolving

Replies

ME/CFS Science @mecfsscience.org · 18/07/2026

1) 🇩🇪 The German ME/CFS Research Foundation has supported 7 research projects with a total budget of € 2.4 million. It includes a treatment trial of tafasitamab, which targets B-cells, and a genetic study of families with multiple members affected by ME/CFS A brief overview

24110

ME/CFS Science @mecfsscience.org · 18/07/2026

2) The treatment trial is led by Carmen Scheibenbogen and will be a follow-up study to the randomized Phase II trial of the CD19 antibody inebilizumab. Tafasitamab also targets CD19 but is less expensive, so they want to test if this also works in a subgroup of 38 patients.

1112

Richard Lewis @z3r0gravitas.bsky.social · 18/07/2026

Thanks for summary. The funding is great news, if still relatively modest. And 'omics work is fine and all. But I'm not enthused on Losartan (why might that help?). And steroids, yikes! Unless they're monitoring for long term deterioration to show their risks.

120